Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Insys Theraptcs Cmn (INSY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 887,920
  • Shares Outstanding, K 72,130
  • Annual Sales, $ 242,280 K
  • Annual Income, $ 7,590 K
  • 36-Month Beta 0.88
  • Price/Sales 3.78
  • Price/Cash Flow 48.00
  • Price/Book 3.42

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.97 +2.84%
on 07/12/17
14.00 -12.07%
on 06/26/17
+0.23 (+1.90%)
since 06/20/17
3-Month
10.12 +21.64%
on 04/24/17
15.02 -18.04%
on 05/31/17
+1.89 (+18.14%)
since 04/20/17
52-Week
8.70 +41.49%
on 12/08/16
19.96 -38.33%
on 08/10/16
-2.83 (-18.69%)
since 07/20/16

Most Recent Stories

More News
Abbott Labs (ABT) Beats on Q2 Earnings and Sales, View Up

Abbott Labs' (ABT) Q2 performance was strong on solid EPD and Medical Device growth. The stock's guidance for 2017 has also been raised.

ABT : 50.85 (+2.87%)
MLAB : 151.97 (-1.45%)
INSY : 12.31 (-2.99%)
ALGN : 160.17 (+0.56%)
Quest Diagnostics Closes Deal to Acquire 2 Labs in Texas

Quest Diagnostics (DGX) acquires Med Fusion and Clear Point lab businesses to grow in oncology space.

MLAB : 151.97 (-1.45%)
DGX : 109.65 (-0.25%)
INSY : 12.31 (-2.99%)
ALGN : 160.17 (+0.56%)
Insys Therapeutics to Report Second Quarter 2017 Results on August 3, 2017

Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "Company") today announced that the Company will release its second quarter 2017 financial results on Thursday, August 3, 2017, before the U.S. financial...

INSY : 12.31 (-2.99%)
Align Technology Hits a 52-Week High on Solid Prospects

Share price of San Jose, CA-based Align Technology, Inc. (ALGN) reached a new 52-week high of $157.86 on Jul 17, eventually closing a bit lower at $156.21.

MLAB : 151.97 (-1.45%)
SYK : 147.40 (+0.81%)
INSY : 12.31 (-2.99%)
ALGN : 160.17 (+0.56%)
Medtronic InterStim System Shows Five-Year Positive Results

Medtronic plc (MDT) has announced that its InterStim system provides sustained long-term efficacy and improved quality of life for overactive bladder (OAB) patients at the end of five years.

MLAB : 151.97 (-1.45%)
INSY : 12.31 (-2.99%)
MDT : 85.67 (+0.02%)
ALGN : 160.17 (+0.56%)
Insys Therapeutics, Inc. Appoints Andrew G. Long as Chief Financial Officer

Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") announced today that Andrew G. Long has joined the company as Chief Financial Officer, effective August 7, 2017.

INSY : 12.31 (-2.99%)
CBM : 58.85 (+0.51%)
Billionaires Bet Big On Canada's Newest $22 Billion Market

OilPrice.com News Commentary

APH.TO : 6.17 (-1.59%)
APHQF : 4.9099 (-1.61%)
GWPH : 114.49 (+1.83%)
INSY : 12.31 (-2.99%)
ABBV : 74.01 (+1.70%)
ZYNE : 18.81 (-1.98%)
Company News for July 17, 2017

Companies In the News are: CYBR,ARNC,T,INSY,TWX

TWX : 99.42 (+0.27%)
T : 36.52 (+1.08%)
ARNC : 24.75 (-1.47%)
CYBR : 42.56 (-0.02%)
INSY : 12.31 (-2.99%)
Hill-Rom (HRC) at 52-Week High: What's Driving the Stock?

Share price of Batesville, IN-based Hill-Rom Holdings, Inc. (HRC) scaled a new 52-week high of $84.17 on Jul 14.

MLAB : 151.97 (-1.45%)
HRC : 83.48 (+0.01%)
INSY : 12.31 (-2.99%)
ALGN : 160.17 (+0.56%)
Insys Therapeutics, Inc. Releases Statement on Payor Interactions

Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") issued a statement today on its interactions with payors:

INSY : 12.31 (-2.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and...

See More

Support & Resistance

2nd Resistance Point 13.07
1st Resistance Point 12.69
Last Price 12.31
1st Support Level 12.09
2nd Support Level 11.87

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.